ABSTRACT.-Pierezan F., Oliveira Filho J.C., Carmo P.M., Aires A.R., Souza T.M., Two experiments were performed in order to determine the toxic effects of varying doses of aϐlatoxins in calves. Clinical, productive and pathologic aspects of affected calves were considered. In the ϐirst experiment, nine 2 to 4-month-old calves Holstein Friesian calves were fed, for two months, daily amounts corresponding to 1.5% of their body weight of a ration containing 500±100 ppb of aϐlatoxins. Three calves of similar age and weight were used as controls and, except for being a ration free of aϐlatoxins, were kept in the same condition as the treated calves. In the second experiment, three 4-5-month old Holstein Friesian calves, were orally fed daily small parcels of a concentrate of aϐlatoxins diluted in 500 ml of water corresponding to 1,250, 2,500 e 5,000 ppb of B1 aϐlatoxin (AFB1). A male 4-month-old Holstein Friesian calf was used as control. During all the experimental period of the ϐirst experiment, the weight gain of the calves receiving AFB1 was equivalent to that of the control group. In the ϐirst experiment no differences were observed between treated and control calves when the values of serum activity of aspartate transaminase (AST), serum albumin (SA), total serum protein (TP), and PVC, determined weekly, were compared. However there was a signiϐicant difference between treated and control groups in the serum activities of alkaline phosphatase (AP) and gamma glutamyl transferase when the serum sampled on the 63th day of the experiment was considered. During the whole experimental period and up to three weeks after the ϐinal of the experiment, no clinical signs or histopathological changes associated with the consumption of aϐlatoxins were observed in any of the calves of the ϐirst experiment. In the second experiment, clinical signs observed in three treated calves included loss of appetite, decrease in weight gain, and loss of weight. Jaundice, intermittent diarrhea, tenesmus and apathy were only observed in the calf receiving 5,000 ppb of AFB1. Due to these clinical signs the calf was euthanized. Increased activity of AF and GGT were observed in all the calves of the treated group during most part of the experimental period. A marked drop in the serum levels of SA was observed in the serum sampled on the 49º day of the experiment in the calf receiving the largest dose of aϐlatoxin. No changes were observed regarding PCV, TP, total bilirubin, direct bilirubin and in the serum activity of AST in any of the calves of the second experiment. Histopathological changes in intoxicated calves included bile duct proliferation, cytoplasmic vacuolar hepatocelular degeneration consistent with hepatocelular deposit of lipids, periportal to brid-